Home › Multiple Myeloma › Nebraska › Lincoln
Multiple Myeloma clinical trials in Lincoln, NE
3 studies for Multiple Myeloma are looking for participants at sites in and around Lincoln (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RecruitingPhase 3
- NHO Revive Research Institute, LLC, Lincoln
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Bryan Medical Center, Lincoln
- NHO Revive Research Institute, LLC, Lincoln
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- NHO Revive Research Institute, LLC /ID# 267869, Lincoln
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in Lincoln
- Non-Small Cell Lung Cancer16 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Coronary Artery Disease5 studies
- Breast Cancer4 studies
- Obesity4 studies
- Schizophrenia4 studies
- Colorectal Cancer4 studies
- Melanoma3 studies
- Amyotrophic Lateral Sclerosis3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.